TCG Crossover Management, LLC
- SEC CIK
- 0001839948
- Latest filing
- Aug 14, 2026
ANTX holding history
AN2 Therapeutics, Inc. in every 13F filed by TCG Crossover Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ANTX overviewAll 13F holders of ANTXFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −1,555,118−100.0% | Sold out | Holders |
| Q3 2024 | 1,555,118 | $1.66M | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 1,555,118 | $3.34M | 0.3% | 00.0% | Unchanged | Holders |
| Q1 2024 | 1,555,118 | $5.05M | 0.4% | −1,123,091−41.9% | Reduced | Holders |
| Q4 2023 | 2,678,209 | $54.9M | 6.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 2,678,209 | $43.1M | 6.3% | +1,388,889+107.7% | Added | Holders |
| Q2 2023 | 1,289,320 | $11.0M | 1.8% | +1,289,320 | New | Holders |